Management of prostatic carcinoma
Patients considering a PSA test should be informed that at present:
- early detection and treatment of prostate cancer may be beneficial
- identifying men at greatest risk of prostate cancer or identifying which patients will benefit from further investigations and treatment is indecisive
- no strong evidence to indicate which treatment option is most suitable for which man;
- active treatments have significant side-effects, although improvements to treatment regimes and their side-effects are being made (1)
The management of prostatic carcinoma depends on the disease stage:
- organ-confined
- locally advanced
- advanced, metastatic
Reference:
Related pages
- Management of organ-confined (localised) prostatic carcinoma
- Management of locally advanced prostatic carcinoma
- Management of advanced, metastatic prostatic carcinoma
- Urological cancer (urgent referral guidance for suspected cancer)
- Diagram of the staging of prostate cancer
- Risk stratification for men with localised prostate cancer
- Follow-up
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.